Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v4-FR Version v1-EN
Language French English
Date Updated 2021-11-25 2021-10-28
Drug Identification Number 00872644 00872644
Brand name AMPICILLIN SODIUM FOR INJECTION, USP AMPICILLIN SODIUM FOR INJECTION, USP
Common or Proper name AMPICILLIN SODIUM INJ 250MG AMPICILLIN SODIUM INJ 250MG
Company Name TEVA CANADA LIMITED TEVA CANADA LIMITED
Ingredients AMPICILLIN AMPICILLIN
Strength(s) 250MG 250MG
Dosage form(s) POWDER FOR SOLUTION POWDER FOR SOLUTION
Route of administration INTRAVENOUS INTRAMUSCULAR INTRAVENOUS INTRAMUSCULAR INTRAVENOUS INTRAMUSCULAR INTRAVENOUS INTRAMUSCULAR
Packaging size 10pk 10pk
ATC code J01CA J01CA
ATC description BETA-LACTAM ANTIBACTERIALS, PENICILLINS BETA-LACTAM ANTIBACTERIALS, PENICILLINS
Reason for shortage Demand increase for the drug. Demand increase for the drug.
Anticipated start date
Actual start date 2021-10-26 2021-10-26
Estimated end date 2021-11-30 2021-11-30
Actual end date 2021-11-24
Shortage status Resolved Actual shortage
Tier 3 Status No No
Company comments
Health Canada comments